A detailed history of Icon Advisers Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Icon Advisers Inc holds 28,500 shares of BMY stock, worth $1.66 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
28,500
Previous 28,500 -0.0%
Holding current value
$1.66 Million
Previous $1.18 Million 24.6%
% of portfolio
0.33%
Previous 0.28%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $1.09 Million - $1.22 Million
-18,900 Reduced 39.87%
28,500 $1.65 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $156 - $92,208
-1,200 Reduced 2.47%
47,400 $3.37 Million
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $936,798 - $1.03 Million
-12,900 Reduced 20.98%
48,600 $3.74 Million
Q1 2021

May 05, 2021

BUY
$59.34 - $66.74 $557,796 - $627,356
9,400 Added 18.04%
61,500 $3.88 Million
Q4 2020

Feb 02, 2021

SELL
$57.74 - $65.43 $6.57 Million - $7.45 Million
-113,793 Reduced 68.59%
52,100 $3.23 Million
Q2 2020

Aug 03, 2020

SELL
$54.82 - $64.09 $422,114 - $493,493
-7,700 Reduced 4.44%
165,893 $9.76 Million
Q1 2020

May 01, 2020

BUY
$46.4 - $67.43 $6.16 Million - $8.95 Million
132,700 Added 324.51%
173,593 $9.68 Million
Q2 2019

Aug 02, 2019

SELL
$44.62 - $49.34 $5,131 - $5,674
-115 Reduced 0.28%
40,893 $1.85 Million
Q1 2019

May 01, 2019

SELL
$45.12 - $53.8 $609,120 - $726,300
-13,500 Reduced 24.77%
41,008 $1.96 Million
Q4 2018

Feb 04, 2019

BUY
$48.76 - $63.23 $1.23 Million - $1.6 Million
25,308 Added 86.67%
54,508 $2.83 Million
Q3 2018

Nov 05, 2018

BUY
$55.19 - $62.25 $1.61 Million - $1.82 Million
29,200 New
29,200 $1.81 Million
Q4 2017

Feb 06, 2018

SELL
$59.94 - $65.35 $839,160 - $914,899
-14,000 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $773,220 - $892,360
14,000
14,000 $892,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Icon Advisers Inc Portfolio

Follow Icon Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Icon Advisers Inc with notifications on news.